Annual Accounts Payable
$966.40 K
+$299.30 K+44.87%
31 December 2023
Summary:
China Pharma Holdings annual accounts payable is currently $966.40 thousand, with the most recent change of +$299.30 thousand (+44.87%) on 31 December 2023. During the last 3 years, it has fallen by -$268.20 thousand (-21.72%). CPHI annual accounts payable is now -80.43% below its all-time high of $4.94 million, reached on 31 December 2010.CPHI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$390.20 K
+$249.20 K+176.74%
30 September 2024
Summary:
China Pharma Holdings quarterly accounts payable is currently $390.20 thousand, with the most recent change of +$249.20 thousand (+176.74%) on 30 September 2024. Over the past year, it has dropped by -$441.10 thousand (-53.06%). CPHI quarterly accounts payable is now -93.85% below its all-time high of $6.34 million, reached on 30 June 2010.CPHI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.9% | -53.1% |
| 3 y3 years | -21.7% | -34.9% |
| 5 y5 years | -8.9% | -66.3% |
CPHI Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.7% | +44.9% | -59.6% | +176.7% |
| 5 y | 5 years | -29.3% | +44.9% | -71.4% | +176.7% |
| alltime | all time | -80.4% | +1312.9% | -93.8% | +2195.3% |
China Pharma Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $390.20 K(+176.7%) |
| June 2024 | - | $141.00 K(-78.2%) |
| Mar 2024 | - | $647.80 K(-33.0%) |
| Dec 2023 | $966.40 K(+44.9%) | $966.40 K(+16.3%) |
| Sept 2023 | - | $831.30 K(+100.7%) |
| June 2023 | - | $414.10 K(-51.2%) |
| Mar 2023 | - | $848.90 K(+27.3%) |
| Dec 2022 | $667.10 K(-28.0%) | $667.10 K(+53.1%) |
| Sept 2022 | - | $435.60 K(+9.6%) |
| June 2022 | - | $397.50 K(-57.1%) |
| Mar 2022 | - | $927.40 K(+0.1%) |
| Dec 2021 | $926.70 K(-24.9%) | $926.70 K(+54.5%) |
| Sept 2021 | - | $599.70 K(-12.7%) |
| June 2021 | - | $687.10 K(-38.2%) |
| Mar 2021 | - | $1.11 M(-10.0%) |
| Dec 2020 | $1.23 M(-9.6%) | $1.23 M(+24.8%) |
| Sept 2020 | - | $989.60 K(-3.5%) |
| June 2020 | - | $1.03 M(+20.9%) |
| Mar 2020 | - | $847.80 K(-37.9%) |
| Dec 2019 | $1.37 M(+28.8%) | $1.37 M(+18.0%) |
| Sept 2019 | - | $1.16 M(-9.6%) |
| June 2019 | - | $1.28 M(+17.2%) |
| Mar 2019 | - | $1.09 M(+3.0%) |
| Dec 2018 | $1.06 M(-7.0%) | $1.06 M(+80.2%) |
| Sept 2018 | - | $588.70 K(-48.9%) |
| June 2018 | - | $1.15 M(-16.4%) |
| Mar 2018 | - | $1.38 M(+20.7%) |
| Dec 2017 | $1.14 M(-62.7%) | $1.14 M(-39.7%) |
| Sept 2017 | - | $1.89 M(-12.0%) |
| June 2017 | - | $2.15 M(-25.3%) |
| Mar 2017 | - | $2.88 M(-6.0%) |
| Dec 2016 | $3.06 M(+25.5%) | $3.06 M(-12.0%) |
| Sept 2016 | - | $3.48 M(+21.5%) |
| June 2016 | - | $2.86 M(-23.5%) |
| Mar 2016 | - | $3.74 M(+53.5%) |
| Dec 2015 | $2.44 M(-4.4%) | $2.44 M(-43.7%) |
| Sept 2015 | - | $4.33 M(+17.1%) |
| June 2015 | - | $3.70 M(+14.4%) |
| Mar 2015 | - | $3.23 M(+26.7%) |
| Dec 2014 | $2.55 M(+35.9%) | $2.55 M(-18.6%) |
| Sept 2014 | - | $3.13 M(+23.2%) |
| June 2014 | - | $2.54 M(+16.5%) |
| Mar 2014 | - | $2.18 M(+16.2%) |
| Dec 2013 | $1.88 M | $1.88 M(-43.1%) |
| Sept 2013 | - | $3.30 M(-23.6%) |
| June 2013 | - | $4.32 M(+45.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $2.98 M(+4.8%) |
| Dec 2012 | $2.84 M(-8.7%) | $2.84 M(-40.7%) |
| Sept 2012 | - | $4.79 M(-2.3%) |
| June 2012 | - | $4.90 M(-16.2%) |
| Mar 2012 | - | $5.85 M(+88.1%) |
| Dec 2011 | $3.11 M(-37.0%) | $3.11 M(-0.3%) |
| Sept 2011 | - | $3.12 M(+12.8%) |
| June 2011 | - | $2.77 M(-24.5%) |
| Mar 2011 | - | $3.66 M(-25.8%) |
| Dec 2010 | $4.94 M(+24.8%) | $4.94 M(+12.2%) |
| Sept 2010 | - | $4.40 M(-30.6%) |
| June 2010 | - | $6.34 M(+49.5%) |
| Mar 2010 | - | $4.24 M(+7.2%) |
| Dec 2009 | $3.96 M(+277.2%) | $3.96 M(+8.8%) |
| Sept 2009 | - | $3.64 M(+4.7%) |
| June 2009 | - | $3.48 M(+56.3%) |
| Mar 2009 | - | $2.23 M(+112.0%) |
| Dec 2008 | $1.05 M(+252.9%) | $1.05 M(+107.5%) |
| Sept 2008 | - | $505.70 K(-16.8%) |
| June 2008 | - | $607.50 K(+2.8%) |
| Mar 2008 | - | $590.70 K(+98.7%) |
| Dec 2007 | $297.30 K(-40.5%) | $297.30 K(-62.0%) |
| Sept 2007 | - | $781.60 K(-6.4%) |
| June 2007 | - | $835.30 K(-6.6%) |
| Mar 2007 | - | $894.00 K(+78.8%) |
| Dec 2006 | $499.90 K(-26.4%) | $499.90 K(-52.4%) |
| Sept 2006 | - | $1.05 M(-26.6%) |
| June 2006 | - | $1.43 M(-11.3%) |
| Mar 2006 | - | $1.61 M(-25.5%) |
| Dec 2005 | $679.10 K(+892.8%) | - |
| Sept 2005 | - | $2.17 M(+1538.2%) |
| Mar 2005 | - | $132.20 K(+37.0%) |
| Dec 2004 | - | $96.50 K(+22.0%) |
| Sept 2004 | - | $79.10 K(+15.6%) |
| June 2004 | $68.40 K(-64.0%) | $68.40 K(+55.5%) |
| Mar 2004 | - | $44.00 K(0.0%) |
| Dec 2003 | - | $44.00 K(+0.7%) |
| Sept 2003 | - | $43.70 K(-77.0%) |
| June 2003 | $190.20 K(-5.0%) | $190.20 K(-0.7%) |
| Mar 2003 | - | $191.60 K(-1.8%) |
| Dec 2002 | - | $195.20 K(-2.5%) |
| Sept 2002 | - | $200.20 K(0.0%) |
| June 2002 | $200.20 K | $200.20 K(+408.1%) |
| Mar 2002 | - | $39.40 K(-4.6%) |
| Dec 2001 | - | $41.30 K(+142.9%) |
| Sept 2001 | - | $17.00 K |
FAQ
- What is China Pharma Holdings annual accounts payable?
- What is the all time high annual accounts payable for China Pharma Holdings?
- What is China Pharma Holdings annual accounts payable year-on-year change?
- What is China Pharma Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for China Pharma Holdings?
- What is China Pharma Holdings quarterly accounts payable year-on-year change?
What is China Pharma Holdings annual accounts payable?
The current annual accounts payable of CPHI is $966.40 K
What is the all time high annual accounts payable for China Pharma Holdings?
China Pharma Holdings all-time high annual accounts payable is $4.94 M
What is China Pharma Holdings annual accounts payable year-on-year change?
Over the past year, CPHI annual accounts payable has changed by +$299.30 K (+44.87%)
What is China Pharma Holdings quarterly accounts payable?
The current quarterly accounts payable of CPHI is $390.20 K
What is the all time high quarterly accounts payable for China Pharma Holdings?
China Pharma Holdings all-time high quarterly accounts payable is $6.34 M
What is China Pharma Holdings quarterly accounts payable year-on-year change?
Over the past year, CPHI quarterly accounts payable has changed by -$441.10 K (-53.06%)